OCT 17, 2017 03:31 PM PDT

A Liquid Biopsy for Retinoblastoma

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Before chemotherapy can be injected into a cancer-ridden eye, doctors must first release some of the eye fluid, also known as aqueous humor. As it turns out, this fluid, typically regarded as waste, contains enough genetic material that can be used to diagnose a tumor condition, all without removing the eye.

Known as retinoblastoma, the genetic condition causes cancer cells to grow in the retina, impairing vision and even necessitating the removal of the eye itself. The disease is found exclusively in young children, and accounts for 3 percent of childhood cancers.

While scientists now know the gene involved in the condition, RB1, there remains limited ways to use this information in the diagnostic arena. Currently, retinoblastoma is diagnosed based on family history and the presence of some characteristic symptoms, such as leukocoria (abnormal retina, also known as amaurotic cat’s eye reflex), vision impairments, and/or strabismus (cross-eye). True confirmation of retinoblastoma has to be done through a biopsy, but these are not only invasive but dangerous as they can spread cancer cells to outside of the eye.

In thinking about this problem, researchers at the University of Southern California realized there was a source of genetic material hidden in plain sight. That is, the aqueous humor that’s typically taken out before chemotherapy is ripe for diagnostic testing, they thought.

"Just as I was discarding the aqueous humor, I wondered if there was a possibility it contained tumor-derived genetic material we could use to better treat our patients," said Jesse Berry, MD, ocular oncologist at CHLA, assistant professor of Clinical Ophthalmology at the USC Roski Eye Institute, and the lead study author. "In fact, we found measurable amounts of tumor DNA -- genetic information from the tumor that had previously been completely unavailable from an intact eye."

They tested the hypothesis in six samples obtained from three eyes affected with retinoblastoma. "Chromosomal changes from DNA found in the aqueous humor corroborates the chromosomal changes found in the retinoblastoma tumor," said James Hicks, PhD, professor of Biologic Sciences at the USC Michelson Center for Convergent Bioscience and professor at the Keck School of Medicine at USC, and the study’s senior author. "These findings provide proof of principle that the aqueous humor can be used for a surrogate 'liquid' tumor biopsy."

"Until now, we could only do genetic analysis -- and base therapy on the specific pathologic tumor features -- when there was no longer a possibility of saving the eye," said Thomas C. Lee, MD, director of the Vision Center at CHLA, and associate professor at the USC Roski Eye Institute, and the study’s co-author. "In the future we hope to have the capability to specifically target therapy to the type of tumor and can anticipate better outcomes for children with retinoblastoma."

"This research has the potential to completely transform how we treat children with retinoblastoma," said Jonathan W. Kim, MD, director of the Retinoblastoma Program at CHLA and also director of the ocular oncology service at USC Roski Eye Institute, and the study’s co-author. "This is one of the most significant findings in retinoblastoma research in the past 20 years."

Additional sources: University of Southern California

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 23, 2018
Clinical & Molecular DX
JUN 23, 2018
Algorithm-Based Blood Test Diagnoses Autism
As a developmental disorder, autism spectrum disorders (ASD) can be diagnosed as early as 18 to 24 months of age, but often the diagnosis does not come unt...
JUN 30, 2018
Immunology
JUN 30, 2018
CD4 T Cells Responsible for Inflammatory Bowel Disease
A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study point...
SEP 05, 2018
Clinical & Molecular DX
SEP 05, 2018
Iron-based MRI Contrast Outperforms Less Safe Method
A new method for loading iron inside nanoparticles creates MRI contrast agents that work better than the mainstay gadolinium chelates, which face increased...
SEP 17, 2018
Microbiology
SEP 17, 2018
Detecting Dangerous Latent Viruses
Evidence mounts that viruses play a role in disease development....
NOV 29, 2018
Genetics & Genomics
NOV 29, 2018
Pet Genomics Might Need to be Leashed
Experts say genetic testing for pets is not quite ready for the market, but that hasn't stopped companies from selling tests....
DEC 05, 2018
Videos
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
Loading Comments...